- call +1-201-465-4211
- email sales@mrinsights.biz
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Scope of the Report:
The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period.
Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025.
North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet.
The worldwide market for Orally Disintegrating Tablet is expected to grow at a CAGR of roughly 11.3% over the next five years, will reach 21300 million US$ in 2024, from 11200 million US$ in 2019, according to a new study.
This report focuses on the Orally Disintegrating Tablet in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Market Segment by Applications, can be divided into
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orally Disintegrating Tablet product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet, with price, sales, revenue and global market share of Orally Disintegrating Tablet in 2017 and 2018.
Chapter 3, the Orally Disintegrating Tablet competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablet breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Orally Disintegrating Tablet market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Orally Disintegrating Tablet sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Orally Disintegrating Tablet Introduction
1.2 Market Analysis by Type
1.2.1 Anti-Psychotics Drug
1.2.2 Anti-Epileptics Drug
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 CNS Diseases
1.3.2 Gastrointestinal Diseases
1.3.3 CVS Diseases
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Orally Disintegrating Tablet Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Orally Disintegrating Tablet Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Orally Disintegrating Tablet Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Orally Disintegrating Tablet Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Johnson and Johnson
2.5.1 Business Overview
2.5.2 Orally Disintegrating Tablet Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 GSK
2.6.1 Business Overview
2.6.2 Orally Disintegrating Tablet Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GSK Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Otsuka
2.7.1 Business Overview
2.7.2 Orally Disintegrating Tablet Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Otsuka Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Eli Lilly and Company
2.8.1 Business Overview
2.8.2 Orally Disintegrating Tablet Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 AstraZeneca
2.9.1 Business Overview
2.9.2 Orally Disintegrating Tablet Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Bristol-Myers Squibb
2.10.1 Business Overview
2.10.2 Orally Disintegrating Tablet Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Conquer
2.11.1 Business Overview
2.11.2 Orally Disintegrating Tablet Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Conquer Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Orally Disintegrating Tablet Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Orally Disintegrating Tablet Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Orally Disintegrating Tablet Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Orally Disintegrating Tablet Manufacturer Market Share in 2018
3.3.2 Top 6 Orally Disintegrating Tablet Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Orally Disintegrating Tablet Market Analysis by Regions
4.1 Global Orally Disintegrating Tablet Sales, Revenue and Market Share by Regions
4.1.1 Global Orally Disintegrating Tablet Sales and Market Share by Regions (2014-2019)
4.1.2 Global Orally Disintegrating Tablet Revenue and Market Share by Regions (2014-2019)
4.2 North America Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
4.3 Europe Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
4.5 South America Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
5 North America Orally Disintegrating Tablet by Country
5.1 North America Orally Disintegrating Tablet Sales, Revenue and Market Share by Country
5.1.1 North America Orally Disintegrating Tablet Sales and Market Share by Country (2014-2019)
5.1.2 North America Orally Disintegrating Tablet Revenue and Market Share by Country (2014-2019)
5.2 United States Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
5.3 Canada Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
5.4 Mexico Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
6 Europe Orally Disintegrating Tablet by Country
6.1 Europe Orally Disintegrating Tablet Sales, Revenue and Market Share by Country
6.1.1 Europe Orally Disintegrating Tablet Sales and Market Share by Country (2014-2019)
6.1.2 Europe Orally Disintegrating Tablet Revenue and Market Share by Country (2014-2019)
6.2 Germany Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
6.3 UK Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
6.4 France Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
6.5 Russia Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
6.6 Italy Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
7 Asia-Pacific Orally Disintegrating Tablet by Country
7.1 Asia-Pacific Orally Disintegrating Tablet Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Orally Disintegrating Tablet Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Orally Disintegrating Tablet Revenue and Market Share by Country (2014-2019)
7.2 China Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
7.3 Japan Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
7.4 Korea Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
7.5 India Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
8 South America Orally Disintegrating Tablet by Country
8.1 South America Orally Disintegrating Tablet Sales, Revenue and Market Share by Country
8.1.1 South America Orally Disintegrating Tablet Sales and Market Share by Country (2014-2019)
8.1.2 South America Orally Disintegrating Tablet Revenue and Market Share by Country (2014-2019)
8.2 Brazil Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
8.3 Argentina Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
8.4 Colombia Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
9 Middle East and Africa Orally Disintegrating Tablet by Countries
9.1 Middle East and Africa Orally Disintegrating Tablet Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Orally Disintegrating Tablet Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Orally Disintegrating Tablet Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
9.3 Turkey Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
9.4 Egypt Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
9.5 Nigeria Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
9.6 South Africa Orally Disintegrating Tablet Sales and Growth Rate (2014-2019)
10 Global Orally Disintegrating Tablet Market Segment by Type
10.1 Global Orally Disintegrating Tablet Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Orally Disintegrating Tablet Sales and Market Share by Type (2014-2019)
10.1.2 Global Orally Disintegrating Tablet Revenue and Market Share by Type (2014-2019)
10.2 Anti-Psychotics Drug Sales Growth and Price
10.2.1 Global Anti-Psychotics Drug Sales Growth (2014-2019)
10.2.2 Global Anti-Psychotics Drug Price (2014-2019)
10.3 Anti-Epileptics Drug Sales Growth and Price
10.3.1 Global Anti-Epileptics Drug Sales Growth (2014-2019)
10.3.2 Global Anti-Epileptics Drug Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Orally Disintegrating Tablet Market Segment by Application
11.1 Global Orally Disintegrating Tablet Sales Market Share by Application (2014-2019)
11.2 CNS Diseases Sales Growth (2014-2019)
11.3 Gastrointestinal Diseases Sales Growth (2014-2019)
11.4 CVS Diseases Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Orally Disintegrating Tablet Market Forecast (2019-2024)
12.1 Global Orally Disintegrating Tablet Sales, Revenue and Growth Rate (2019-2024)
12.2 Orally Disintegrating Tablet Market Forecast by Regions (2019-2024)
12.2.1 North America Orally Disintegrating Tablet Market Forecast (2019-2024)
12.2.2 Europe Orally Disintegrating Tablet Market Forecast (2019-2024)
12.2.3 Asia-Pacific Orally Disintegrating Tablet Market Forecast (2019-2024)
12.2.4 South America Orally Disintegrating Tablet Market Forecast (2019-2024)
12.2.5 Middle East and Africa Orally Disintegrating Tablet Market Forecast (2019-2024)
12.3 Orally Disintegrating Tablet Market Forecast by Type (2019-2024)
12.3.1 Global Orally Disintegrating Tablet Sales Forecast by Type (2019-2024)
12.3.2 Global Orally Disintegrating Tablet Market Share Forecast by Type (2019-2024)
12.4 Orally Disintegrating Tablet Market Forecast by Application (2019-2024)
12.4.1 Global Orally Disintegrating Tablet Sales Forecast by Application (2019-2024)
12.4.2 Global Orally Disintegrating Tablet Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Orally Disintegrating Tablet Picture
Table Product Specifications of Orally Disintegrating Tablet
Figure Global Sales Market Share of Orally Disintegrating Tablet by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
